SCF ENCYCLOPEDIA ENTRY

SEPTIC PELVIC THROMBOPHLEBITIS (POSTPARTUM)

SCF-RDOS Registry Code: SCF-RDOS-PPD-INF-002

Disease Type Classification: Postpartum Infectious-Vascular Disorder → Septic Thromboinflammatory Syndrome → Septic Pelvic Thrombophlebitis

Adaptive Module Activation:

• Universal Core Module
• Infectious Disease Expansion
• Vascular Disease Expansion
• Hematologic Disease Expansion
• Thromboinflammatory Expansion
• Sepsis Expansion
• Critical Care Expansion

1. SCOPE & POSITIONING

Etiology / Classification

Septic Pelvic Thrombophlebitis (SPT) is a rare but serious postpartum thromboinfectious disorder characterized by infected thrombus formation within pelvic venous structures following childbirth.

The condition most commonly develops after:

• Postpartum Endometritis
• Cesarean delivery
• Prolonged labor
• Pelvic infection
• Obstetric surgical procedures
• Severe postpartum uterine infection

The disease typically involves:

• Ovarian veins
• Uterine venous plexuses
• Internal iliac venous branches
• Pelvic venous drainage networks

Within the SCF framework, Septic Pelvic Thrombophlebitis is classified as:

A postpartum thromboinfectious vascular failure syndrome characterized by microbial invasion of pelvic venous structures, septic thrombus formation, endothelial injury, persistent inflammatory activation, and risk of systemic septic dissemination.

SCF Classification

SCF Disease Category: Infectious-Thromboinflammatory Vascular Syndrome

SCF Functional Class:

Maternal Septic Venous Dysregulation Disorder

SCF Fault Tier Classification

Clinical Significance

SPT is an important cause of persistent postpartum fever that fails to respond adequately to antimicrobial therapy.

Potential complications include:

• Persistent bacteremia
• Septic embolization
• Ovarian vein thrombosis
• Pulmonary embolism
• Sepsis
• Septic shock
• Multiorgan dysfunction
• Maternal mortality

SCF Domain Alignment

Primary Domains:

• Vascular
• Infectious
• Hematologic
• Inflammatory

Secondary Domains:

• Reproductive
• Immunologic
• Cardiovascular
• Critical Care

2. ETIOPATHOGENIC CORE

Primary Cause

Septic Pelvic Thrombophlebitis develops when postpartum pelvic infection extends into damaged venous structures, triggering endothelial injury, coagulation activation, microbial colonization, and septic thrombus formation.

The disease represents convergence of:

• Infection
• Hypercoagulability
• Endothelial injury

Consistent with Virchow’s triad.

Key Drivers

Driver A — Postpartum Hypercoagulability

The postpartum state naturally promotes:

• Increased coagulation factor activity
• Reduced fibrinolysis
• Enhanced thrombosis susceptibility

Result:

• Venous clot formation

Driver B — Endothelial Injury

Delivery-associated trauma causes:

• Vascular disruption
• Endothelial activation
• Procoagulant signaling

Result:

• Thrombus initiation

Driver C — Microbial Venous Invasion

Bacteria invade:

• Pelvic venous structures
• Existing thrombi
• Endothelial surfaces

Result:

• Septic thrombosis

Driver D — Persistent Inflammatory Amplification

Activated pathways include:

• Cytokine cascades
• Complement activation
• Neutrophil recruitment

Result:

• Ongoing fever and inflammation

Driver E — Septic Embolization

Fragments of infected thrombus may enter:

• Inferior vena cava
• Pulmonary circulation

Result:

• Pulmonary septic emboli

3. SCF FAULT ARCHITECTURE

4. PATHOGENESIS FLOW (SCF LOGIC)

Postpartum Uterine Infection

↓

Pelvic Venous Exposure

↓

Endothelial Injury

Hypercoagulability

↓

Venous Thrombus Formation

↓

Bacterial Colonization

↓

Septic Thrombus Development

↓

Persistent Cytokine Activation

↓

Recurrent Fever

↓

Septic Pelvic Thrombophlebitis

↓

Septic Embolization

↓

Sepsis and Organ Dysfunction

5. CLINICAL SPECTRUM

6. SCF TRINITY FRAMEWORK MAPPING

Trinity Axis I — Structural Integrity

Affected Systems:

• Pelvic veins
• Ovarian veins
• Venous endothelium
• Pelvic vascular networks

Primary Failure:

• Septic destruction of venous integrity

Trinity Axis II — Energetic Integrity

Affected Systems:

• Endothelial metabolism
• Immune-cell energetics
• Tissue repair systems

Primary Failure:

• Infection-driven vascular energetic collapse

Trinity Axis III — Informational Integrity

Affected Systems:

• Coagulation signaling
• Inflammatory signaling
• Endothelial communication networks

Primary Failure:

• Dysregulated thromboinflammatory signaling

7. SEPTIC PELVIC THROMBOPHLEBITIS EXPANSION MODULE

Clinical Subtype Registry

Type A

Deep Septic Pelvic Thrombophlebitis

Characteristics:

• Small pelvic venous involvement
• Difficult imaging detection

Type B

Ovarian Vein Thrombophlebitis

Characteristics:

• Most recognizable subtype
• Frequently right-sided

Type C

Endometritis-Associated SPT

Characteristics:

• Direct extension from uterine infection

Type D

Septic Embolic SPT

Characteristics:

• Pulmonary septic emboli
• Systemic dissemination

Type E

Fulminant Septic Thromboinflammatory Syndrome

Characteristics:

• Sepsis
• Multiorgan dysfunction
• ICU requirement

8. MULTI-OMICS PATHOGENESIS MAP

9. SCF PCR THERAPEUTIC STRATEGY

PREVENTATIVE

Objectives

Prevent progression from pelvic infection to septic thrombosis.

Targets:

• Early infection control
• Endothelial protection
• Thrombotic risk reduction
• Pelvic infection surveillance

CURATIVE

Objectives

Eliminate infection and resolve thrombotic disease.

Targets:

• Septic thrombus
• Bacterial burden
• Inflammatory activation
• Venous dysfunction

Interventions:

• Broad-spectrum antimicrobial therapy
• Anticoagulation when clinically indicated
• Sepsis management
• Critical care monitoring

RESTORATIVE

Objectives

Restore vascular integrity and prevent long-term complications.

Targets:

• Endothelial recovery
• Venous remodeling
• Inflammatory resolution
• Reproductive health preservation

Potential strategies:

• SCF-derived thromboimmune restoration platforms
• Endothelial regenerative therapeutics
• Precision anti-inflammatory systems
• Long-term vascular resilience programs

10. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Clinical Assessment

Characteristic findings:

• Persistent postpartum fever
• Fever despite antibiotic therapy
• Pelvic pain
• Lower abdominal discomfort
• Tachycardia

Laboratory Evaluation

• CBC
• Blood cultures
• CRP
• Procalcitonin
• D-dimer
• Coagulation profile

Imaging

Preferred modalities:

• Contrast-enhanced CT
• MRI venography

May reveal:

• Ovarian vein thrombosis
• Pelvic venous thrombosis
• Perivascular inflammation

Treatment

Antimicrobial Therapy

Broad-spectrum intravenous antibiotics remain essential.

Anticoagulation

Frequently utilized when:

• Ovarian vein thrombosis is identified
• Extensive thrombosis is present
• Persistent symptoms continue despite antibiotics

Critical Care Support

For severe disease:

• Sepsis protocols
• Hemodynamic monitoring
• Organ-support therapies

11. SCF THERAPEUTIC ENGINEERING OPPORTUNITIES

SCF Target Cluster A

Thromboimmune Regulation Platform

Targets:

• Coagulation activation
• Immune-thrombus interactions
• Septic clot stabilization

SCF Target Cluster B

Endothelial Restoration Platform

Targets:

• Vascular repair
• Endothelial resilience
• Inflammatory resolution

SCF Target Cluster C

Precision Anti-Infective Platform

Targets:

• Polymicrobial infections
• Biofilm-associated pathogens
• Septic thrombus penetration

SCF Target Cluster D

Vascular Recovery Platform

Targets:

• Venous remodeling
• Embolic risk reduction
• Long-term vascular function

12. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Infection

• Procalcitonin
• CRP
• Blood culture positivity

Thrombosis

• D-dimer
• Fibrin degradation products
• Thrombin generation markers

Endothelial Injury

• von Willebrand factor
• Soluble thrombomodulin
• Endothelial microparticles

Sepsis Monitoring

• Lactate
• Organ dysfunction biomarkers

Clinical Endpoints

Primary:

• Resolution of fever

Secondary:

• Clearance of infection
• Thrombus resolution
• Prevention of embolic complications
• Prevention of sepsis

FDA Translational Pathway

Preclinical

↓

IND

↓

Phase I Safety

↓

Phase II Thromboinfectious Resolution Studies

↓

Phase III Maternal Outcome and Sepsis Prevention Trials

↓

NDA/BLA Submission

13. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Immune and endothelial cells fail to contain microbial invasion while simultaneously activating pathologic coagulation pathways.

Tissue Layer

Pelvic venous structures become sites of persistent infected thrombus formation.

Organ Layer

The reproductive and vascular systems lose coordinated control of postpartum recovery and microbial containment.

System Layer

Coagulation, immune, vascular, and inflammatory networks become synchronized into a self-sustaining thromboinfectious state.

Whole-Organism Layer

The maternal recovery program becomes diverted from physiologic healing into a pathological cycle of infection, thrombosis, inflammation, and systemic dissemination.

14. SCF LAYMAN’S SUMMARY

Septic Pelvic Thrombophlebitis is a rare but serious complication that can occur after childbirth when an infection spreads into pelvic veins and causes infected blood clots to form.

According to the SCF model, postpartum tissues are healing from delivery while the body is naturally in a more clot-prone state. If bacteria invade damaged pelvic veins, infected clots can develop and trigger persistent inflammation.

Common symptoms include:

• Persistent fever
• Pelvic pain
• Lower abdominal pain
• Rapid heart rate
• Continued illness despite antibiotic treatment

One of the most important clues is a postpartum fever that does not improve as expected with antibiotics. In severe cases, infected clots can spread infection throughout the body or travel to the lungs, causing life-threatening complications.

SCF-RDOS INDICATION SUMMARY